Physician profile
Jane V Loman
NPI 1346274024
$6,601.25
in general payments reported to CMS, 2019-2025
28 companies · $1,540 in 2025
The $1,540 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $730 · 2020: $304 · 2021: $353 · 2022: $910 · 2023: $1,403 · 2024: $1,361 · 2025: $1,540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,286 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,285.94 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,126.46 | 2019-2025 | Clareon, Rocklatan, Hydrus Microstent |
| Abbvie INC. | $1,024.73 | 2022-2025 | |
| Glaukos Corporation | $869.46 | 2019-2025 | Idosetr, Istent Infinite |
| New World Medical,INC. | $563.65 | 2023-2025 | Streamline, Kahook Dual Blade, Clearpath |
| Oyster Point Pharma, INC. | $545.26 | 2022-2025 | Tyrvaya, Ryzumvi, Tyrvaya |
| Allergan, INC. | $378.17 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $352.56 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Sun Pharmaceutical Industries INC. | $291.63 | 2020-2025 | Cequa |
| Aerie Pharmaceuticals, INC. | $282.87 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $221.85 | 2022-2024 | Acthar |
| Sight Sciences, INC. | $137.37 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Harrow Eye, LLC | $111.85 | 2024-2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $106.24 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $84.75 | 2024 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $84.39 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $52.47 | 2019 | |
| Ivantis, INC | $49.74 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $46.37 | 2023-2024 | Tecnis Iol, Tecnis Iol, Tecnis Simplicity |
| Thea Pharma INC. | $39.25 | 2024-2025 | Iyuzeh |
| Rxsight INC | $38.43 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Carl Zeiss Meditec USA, INC. | $36.95 | 2023 | Cirrus Hd-Oct |
| Apellis Pharmaceuticals, INC. | $34.91 | 2025 | Syfovre |
| Akorn, INC. | $23.61 | 2020 | |
| Kala Pharmaceuticals, INC. | $23.34 | 2021 | |
| Dompe US, INC. | $22.13 | 2025 | Oxervate |
| Iridex Corporation | $19.57 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Omeros Corporation | $13.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Loman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.